Viewing Study NCT00408694

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2026-02-03 @ 11:12 PM
Study NCT ID: NCT00408694
Status: COMPLETED
Last Update Posted: 2018-01-30
First Post: 2006-12-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 View
None Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 View
None Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7 View
None Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 View
None Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 View
Keywords: